FasT CAR
Simplified Production
FasT CAR is proprietary and patented technology. FasT CAR production takes overnight for cell culturing, in contrast to conventional CAR approch where cell culturing usually takes 2-3weeks.
Clinical Significance
Patients will not have to wait long to receive drug administration.
Product Type
GC007F, one of the lead program, is redirected to target CD19 for relapsed / refractory B cell acute lymphoblastic leukemia (B-ALL). This product has multiple advantages, including younger phenotype, higher proliferation capabilities, and less exhaustion, and more potent eliminating leukemia malignancies, and capable of infiltrate into bone marrow and spleen.
Overnight Production
* Cell production can be completed within 24 hrs since receipt of cells; while lot releasing test remains the same pre current regulation